Drug Combination May Improve Impact of Immunotherapy in Head and Neck Cancer – UC San Diego Health
UC San Diego Health |
Drug Combination May Improve Impact of Immunotherapy in Head and Neck Cancer
UC San Diego Health Checkpoint inhibitor-based immunotherapy has been shown to be very effective in recurrent and metastatic head and neck cancer but only in a minority of patients. University of California San Diego School of Medicine researchers may have found a way to … |
